Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 16, 2022

View Archived Issues

New DNA-dependent protein kinase inhibitors divulged by Shouyao Holdings

Vasopressin V1A receptor antagonists discovered at Roche

Medshine Discovery identifies SOS1/Gly12Cys mutant GTPase KRAS interaction inhibitors

Betta Pharmaceuticals describes new PTPN11 inhibitors

Merck KGaA, Cancer Research Technology present YAP1/TEAD interaction inhibitors

Akouos presents preclinical data on anti-VEGF AAVAnc80 vector for vestibular schwannoma

ADAM8 drives severity in acute respiratory distress syndrome trough neutrophil migration

Increasing catalase activity reverses estrogen-mediated aging

Aquinnah and Roche collaborate in ALS and neurodegenerative diseases

Alamar and SciNeuro to discover and develop novel therapeutic antibodies for neurological diseases

NTS-104 reduces critical neuroinflammatory signaling in rat embolic stroke model

Persistent Ebolavirus in brain seeds relapses

NIBIOHN and Shionogi announce discovery of novel antiviral antibody for SARS-CoV-2

Memo Therapeutics to advance lead programs

YTHDF1 is involved in renal fibrosis through upregulation of YAP

Financing at Third Harmonic Bio to support development of oral KIT inhibitor THB-001

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...